Literature DB >> 15154912

Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines.

Mona El-Bahrawy1, Richard Poulsom, Andrew J Rowan, Ian T M Tomlinson, Malcolm R Alison, S Richard Poulsom, Ian T Tomlinson.   

Abstract

The E-cadherin/catenin complex is a prime mediator of cell-cell adhesion. APC mutations can result in loss of beta-catenin downregulation and an accumulation of beta-catenin in the cell. Beta-CATENIN mutations can have a similar effect. The aim of this study was to investigate the effect of beta-CATENIN and APC mutations on the expression and assembly of the E-cadherin/catenin complex. Five colorectal carcinoma cell lines with different APC and beta-CATENIN gene status were selected and mutations were confirmed. The expression of members of the E-cadherin/catenin complex was studied by immunohistochemistry and Western blotting. Complex assembly was investigated by immunoprecipitation. It is shown that E-cadherin and catenins are expressed in colorectal carcinoma cell lines with the predominant complex assembly being E-cadherin/beta-catenin/alpha-catenin. The subcellular distribution of the proteins is influenced by cell-cell contact, resulting in membranous localization. The expression and assembly of the E-cadherin/catenin complex does not appear to be affected by the presence of APC and or beta-CATENIN mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15154912      PMCID: PMC2517458          DOI: 10.1111/j.0959-9673.2004.0371.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  53 in total

Review 1.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

Review 2.  Armadillo and dTCF: a marriage made in the nucleus.

Authors:  R Cavallo; D Rubenstein; M Peifer
Journal:  Curr Opin Genet Dev       Date:  1997-08       Impact factor: 5.578

3.  Beta-catenin mutations in cell lines established from human colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Rowan; M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  beta-catenin is a target for the ubiquitin-proteasome pathway.

Authors:  H Aberle; A Bauer; J Stappert; A Kispert; R Kemler
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

5.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein.

Authors:  S Munemitsu; I Albert; B Rubinfeld; P Polakis
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.

Authors:  M van de Wetering; R Cavallo; D Dooijes; M van Beest; J van Es; J Loureiro; A Ypma; D Hursh; T Jones; A Bejsovec; M Peifer; M Mortin; H Clevers
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

8.  Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system.

Authors:  M L Hermiston; M H Wong; J I Gordon
Journal:  Genes Dev       Date:  1996-04-15       Impact factor: 11.361

9.  Assembly of the cadherin-catenin complex in vitro with recombinant proteins.

Authors:  H Aberle; S Butz; J Stappert; H Weissig; R Kemler; H Hoschuetzky
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

10.  Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion.

Authors:  C L Adams; W J Nelson; S J Smith
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

View more
  15 in total

1.  Retained cell–cell adhesion in serrated neoplastic pathway as opposed to conventional colorectal adenomas.

Authors:  Xiangsheng Fu; Xiatong Yang; Kequan Chen; Yali Zhang
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

2.  Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression.

Authors:  Natalia Mitin; Laurie Betts; Marielle E Yohe; Channing J Der; John Sondek; Kent L Rossman
Journal:  Nat Struct Mol Biol       Date:  2007-08-19       Impact factor: 15.369

3.  Effects of gastrin 17 on beta-catenin/Tcf-4 pathway in Colo320WT colon cancer cells.

Authors:  Jun Cao; Jie-Ping Yu; Chao-Hong Liu; Lan Zhou; Hong-Gang Yu
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 4.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

5.  Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy.

Authors:  Caroline M Robb; Smit Kour; Jacob I Contreras; Ekta Agarwal; Carter J Barger; Sandeep Rana; Yogesh Sonawane; Beth K Neilsen; Margaret Taylor; Smitha Kizhake; Rhishikesh N Thakare; Sanjib Chowdhury; Jing Wang; Jennifer D Black; Michael A Hollingsworth; Michael G Brattain; Amarnath Natarajan
Journal:  Oncotarget       Date:  2017-12-28

6.  In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.

Authors:  Angélique Virgone-Carlotta; Manon Lemasson; Hichem C Mertani; Jean-Jacques Diaz; Sylvain Monnier; Thomas Dehoux; Hélène Delanoë-Ayari; Charlotte Rivière; Jean-Paul Rieu
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

7.  Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling.

Authors:  Chung-Ming Lin; Hsin-Han Chen; Chun-An Lin; Hui-Chung Wu; Jim Jinn-Chyuan Sheu; Hui-Jye Chen
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

8.  Correlations between TBL1XR1 and recurrence of colorectal cancer.

Authors:  Hongda Liu; Yunfei Xu; Qun Zhang; Kangshuai Li; Dawei Wang; Shuo Li; Shanglei Ning; Hui Yang; Weichen Shi; Zhaochen Liu; Yuxin Chen
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

9.  RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.

Authors:  Johnny Yu; Albertas Navickas; Hosseinali Asgharian; Bruce Culbertson; Lisa Fish; Kristle Garcia; John Paolo Olegario; Maria Dermit; Martin Dodel; Benjamin Hänisch; Yikai Luo; Ethan M Weinberg; Rodrigo Dienstmann; Robert S Warren; Faraz K Mardakheh; Hani Goodarzi
Journal:  Cancer Discov       Date:  2020-06-08       Impact factor: 38.272

10.  INO80 haploinsufficiency inhibits colon cancer tumorigenesis via replication stress-induced apoptosis.

Authors:  Shin-Ai Lee; Han-Sae Lee; Shin-Kyoung Hur; Sang Won Kang; Goo Taeg Oh; Daekee Lee; Jongbum Kwon
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.